Imperative Care, Inc. today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s Zoom System, maki ...

Imperative Care has long been heading toward this new structure. In 2021, upon raking in a series D funding round that added $260 million to its coffers, the company said it would use the ...

Imperative Care is a commercial-stage medical technology company researching, developing and manufacturing connected innovations to elevate care for people affected by devastating vascular ...

Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony™ 16F Catheter, the company’s latest innovation designed to ...

Imperative Care, Inc. a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the appointment of ...

CAMPBELL, Calif., April 22, 2025--Imperative Care, Inc. announces the appointment of Todd Van Horn as Chief Financial Officer.

Imperative Care has completed subject enrolment in the pivotal investigational device exemption (IDE) trial, SYMPHONY-PE, assessing the Symphony thrombectomy system's efficacy and safety in ...

Imperative Care’s method places a narrower Zoom catheter within its large-bore, 0.88-inch system. This allows the clot to be pulled back into the wider opening so it can be captured and ...

Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony™ 16F Catheter, the company’s latest innovation designed to ...